BMP8B mediates the survival of pancreatic cancer cells and regulates the progression of pancreatic cancer

Oncology Reports

Volumn 32, Issue 5, 2014, Pages 1861-1866

  Cheng, Zhuoxin ^a,c   Cui, Wu ^b   Ding, Ye ^a   Liu, Tao ^a   Liu, Weixin ^a   Qin, Youyou ^b   Xia, Weibin ^a   Xu, Jian ^a   Zhang, Yinghai ^a   Zou, Xiaoming ^b  

^a JIAMUSI UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; BMP8B; Overexpression; Pancreatic cancer; ShRNA

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 8B; CASPASE 3; CASPASE 9; LACTATE DEHYDROGENASE; UNCLASSIFIED DRUG; BMP8B PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BMP8B GENE; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CARCINOGENESIS; CELL GROWTH; CELL SURVIVAL; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ASSAY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRIAL MEMBRANE POTENTIAL; PANCREAS CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TUMOR GENE; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

BONE MORPHOGENETIC PROTEINS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PANCREATIC NEOPLASMS;

EID: 84907286908     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3413     Document Type: Article

References (20)

1. Danovi SA, Wong HH and Lemoine NR: Targeted therapies for pancreatic cancer. Br Med Bull 87: 97-130, 2008.
2. Warshaw AL and Fernández-del Castillo C: Pancreatic carcinoma. N Engl J Med 326: 455-465, 1992.
3. Li D, Xie K, Wolff R and Abbruzzese JL: Pancreatic cancer. Lancet 363: 1049-1057, 2004.
4. Bardeesy N and DePinho RA: Pancreatic cancer biology and genetics. Nat Rev Cancer 2: 897-909, 2002.
5. Alarmo EL and Kallioniemi A: Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis? Endocr Relat Cancer 17: R123-R139, 2010.
6. Miyazono K, Kamiya Y and Morikawa M: Bone morphogenetic protein receptors and signal transduction. J Biochem 147: 35-51, 2010.
7. Kim IY and Kim SJ: Role of bone morphogenetic proteins in transitional cell carcinoma cells. Cancer Lett 241: 118-123, 2006.
8. Langenfeld EM, Kong Y and Langenfeld J: Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene 25: 685-692, 2006.
9. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F and Vescovi AL: Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765, 2006.
10. Bleuming SA, He XC, Kodach LL, Hardwick JC, Koopman FA, Ten Kate FJ, van Deventer SJ, Hommes DW, Peppelenbosch MP, Offerhaus GJ, Li L and van den Brink GR: Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice. Cancer Res 67: 8149-8155, 2007.
11. Arnold SF, Tims E and Mcgrath BE: Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2. Cytokine 11: 1031-1037, 1999.
12. Ren W, Sun X, Wang K, Feng H, Liu Y, Fei C, Wan S, Wang W, Luo J, Shi Q, Tang M, Zuo G, Weng Y, He T and Zhang Y: BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression. Mol Biol Rep 41: 1373-1383, 2014.
13. Autzen P, Robson CN, Bjartell A, Malcolm AJ, Johnson MI, Neal DE and Hamdy FC: Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. Br J Cancer 78: 1219-1223, 1998.
14. Alarmo EL, Pärssinen J, Ketolainen JM, Savinainen K, Karhu R and Kallioniemi A: BMP7 influences proliferation, migration, and invasion of breast cancer cells. Cancer Lett 275: 35-43, 2009.
15. Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, Xue DB, Bai X W and Sun B: Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett 293: 99-108, 2010.
16. δδCT method. Methods 25: 402-408, 2001.
17. Spender LC and Inman GJ: Developments in Burkitt's lymphoma: novel cooperations in oncogenic MYC signaling. Cancer Manag Res 6: 27-38, 2014.
18. Mima K, Fukagawa T, Kurashige J, Takano Y, Uchi R, Ueo H, Matsumura T, Ishibashi M, Sawada G, Takahashi Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Watanabe M, Ishii H, Mori M, Baba H, Sasako M and Mimori K: Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer. Oncol Lett 6: 387-392, 2013.
19. Jung SH, Kang KD, Ji D, Fawcett RJ, Safa R, Kamalden TA and Osborne NN: The flavonoid baicalin counteracts ischemic and oxidative insults to retinal cells and lipid peroxidation to brain membranes. Neurochem Int 53: 325-337, 2008.
20. Correa F, Soto V and Zazueta C: Mitochondrial permeability transition relevance for apoptotic triggering in the post-ischemic heart. Int J Biochem Cell Biol 39: 787-798, 2007.